You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

budigalimab

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 26, 2023

Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)

Not yet recruiting
  • Human Immuno-deficiency Virus (HIV) Disease
  • Budigalimab
  • +3 more
  • (no location specified)
Sep 5, 2023

Advanced Solid Tumors Trial in United States (ABBV-706, Cisplatin, Budigalimab)

Recruiting
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +3 more
Dec 13, 2022

Human Immunodeficiency Virus (HIV) Trial in Puerto Rico, United States (Budigalimab, Placebo)

Completed
  • Human Immunodeficiency Virus (HIV)
  • Budigalimab
  • Placebo
  • Bakersfield, California
  • +9 more
Oct 14, 2022

NSCLC, Head and Neck Squamous Cell Carcinoma Trial in Israel, Japan, United States (ABBV-514, Pembrolizumab, Budigalimab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Fullerton, California
  • +13 more
Jul 11, 2022

Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

Recruiting
  • Small Cell Lung Cancer
  • Birmingham, Alabama
  • +32 more
Oct 5, 2022

Hepatocellular Carcinoma Trial in Worldwide (Budigalimab, Livmoniplimab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Budigalimab
  • +3 more
  • Prescott Valley, Arizona
  • +58 more
Apr 10, 2023

Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-151, Budigalimab)

Recruiting
  • Advanced Solid Tumors Cancer
  • New Haven, Connecticut
  • +29 more
Dec 5, 2022